article thumbnail

Navigating new EU regulations in the clinical supply chain

Pharmaceutical Technology

We learn how the EUs new Clinical Trial Regulation (CTR) and the CTIS platform are reshaping clinical trial approvals and the supply chain.

article thumbnail

Logistics in Focus: Orchestrating the Challenges of Cell Therapy

Worldwide Clinical Trials

While clinical supply is essential to any successful trial, autologous cell therapy trials occupy the far end of the spectrum regarding risk tolerance. We offer dedicated Clinical Supply Coordinators for complex IP programs, scaling resources to dovetail into pre-existing frameworks when needed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Almac Expands Cold Chain Capabilities with Multi-Million-Dollar Investment

Pharmaceutical Commerce

The Craigavon investment enhances Almac’s global clinical supply network with upgraded storage, distribution, and shipping capabilities to meet the growing demand for temperature-sensitive medicines.

article thumbnail

Rethinking Inhalation Drug Development

PharmTech

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience Experic July 15th 2025 Article Step into a model designed for adaptability, speed, and success in specialized drug development.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.

article thumbnail

CDMO Solutions – Reducing Risk and Accelerating Time to Market

PharmTech

Related Content Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets Catalent July 16th 2025 Article Rethinking Inhalation Drug Development Experic July 15th 2025 Article What it takes to bring complex inhaled therapies to market—faster and smarter.

article thumbnail

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience

PharmTech

Related Content Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets Catalent July 16th 2025 Article Rethinking Inhalation Drug Development Experic July 15th 2025 Article What it takes to bring complex inhaled therapies to market—faster and smarter.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

(..)

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

(..)

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan.

article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and (..)